• Return to Headlines

Halozyme Therapeutics Bearish Moving Average Crossover Alert (HALO)

By James Quinn

Halozyme Therapeutics (NASDAQ:HALO) shares have crossed bearishly below their 10-day moving average of $13.94 on a volume of 2.8 million shares. This may provide short-term investors a chance for a short position, as such a crossover often suggests lower prices in the near term.

In the past 52 weeks, Halozyme Therapeutics share prices have been bracketed by a low of $6.96 and a high of $25.25 and are now at $13.14, 89% above that low price. Over the past week, the 200-day moving average (MA) has gone down 2% while the 50-day MA has advanced 1.7%.

SmarTrend recommended that subscribers consider buying shares of Halozyme Therapeutics on January 5th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $12.09. Since that recommendation, shares of Halozyme Therapeutics have risen 17.1%. We continue to monitor HALO for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: moving crosses halozyme therapeutics

Ticker(s): HALO